Delivery Order SPE2DR25D3202-SPE2DR26F8E4H
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,866.81 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of December 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) with a ceiling value of $4,766.00. This firm fixed-price delivery order, awarded on November 20, 2025, represents a non-set-aside competitive award with an ultimate completion date of November 21, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% patches (30-count units) under a firm fixed-price contract with a ceiling value of $1,224.60. The order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a competitively awarded non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,727.04 on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is a child contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, allowing AmerisourceBergen to compete openly for this...
- The Defense Logistics Agency has awarded a delivery order valued at $6,443.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $3,936.42. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S under a firm fixed-price contract valued at $4,928.37, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.20 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical distributor will perform this delivery order from its corporate office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,722.08 for Lidocaine 5% Patch 30-count units, with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E4HDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,652.37 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch (30-count units) with an ultimate completion date of January 9, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2031. This delivery order supports the DLA Medical Supply Chain's mission to provide comprehensive pharmaceutical and medical supplies to military treatment facilities and federal healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor and critical federal vendor, regularly fulfills such medical procurement requirements through its broad portfolio of brand-name and generic medications, medical devices, and specialized healthcare commodities. The Lidocaine 5% Patch is a topical pain management product commonly utilized in military and federal healthcare settings for localized pain relief, demonstrating the company's role in delivering essential pharmaceutical commodities across multiple therapeutic domains to support government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 1/7/26 |